The Indian pharmaceutical sector showed mixed performance on February 11, 2026, as of around 10:20 AM IST. The Nifty Pharma index, which tracks major pharma stocks, was trading in a slightly negative territory, reflecting broader market trends where benchmarks like the Nifty 50 and Sensex were flat to marginally lower amid global cues.
Market Overview
- Broader market: Nifty 50 around 25,919–25,985 (flat to slight dip), Sensex around 84,186–84,235 (minor decline).
- Pharma sector: Nifty Pharma closed the previous session at approximately 22,210.50 (down 0.36%), with intraday levels showing limited movement and a mix of advances and declines.
The data provided lists various pharma and related healthcare stocks with their BSE and NSE prices and percentage changes at that time. Key observations include:
- Several stocks posted gains, such as Indraprastha Medical (+6.38% on BSE), Advanced Enzyme Technologies (+6.16%), Sequent Scientific (+4.34%), Aster DM Healthcare (+2.39%), Max Healthcare Institute (+2.34%), and Healthcare Global Enterprises (+2.31%).
- Notable declines were seen in stocks like Windlas Biotech (-4.12%), Jubilant Industries (-4.08%), FDC (-2.69%), Jeena Sikho (-2.75%), and Concord Biotech (-2.10%).
- Major players like Sun Pharma (flat at ~1,708, +0.05%), Cipla (-0.39%), Dr. Reddy’s Labs (near flat), Divis Laboratories (+0.36%), Torrent Pharma (-0.71%), and Aurobindo Pharma (+1.53% on BSE) showed varied but generally modest movements.
Top Gainers (from provided data, % change on BSE/NSE)
- Indraprastha Medical: +6.38% / +6.08%
- Advanced Enzyme Technologies: +6.16% / +5.42%
- Sequent Scientific: +4.34% / +4.53%
- Aster DM Healthcare: +2.39% / +2.40%
- Max Healthcare Institute: +2.34% / +2.16%
Top Losers (from provided data, % change on BSE/NSE)
- Windlas Biotech: -4.12% / -4.11%
- Jubilant Industries: -4.08% / -4.46%
- FDC: -2.69% / -2.82%
- Jeena Sikho: -2.75% / -2.82%
- Concord Biotech: -2.10% / -1.97%
This snapshot reflects early trading activity in the pharma sector, with selective gains in mid-cap and healthcare-related names offsetting pressures on some larger and specialty pharma stocks. Performance can shift as the trading day progresses, influenced by overall market sentiment, Q3 earnings releases, and global factors. For real-time updates, refer to NSE/BSE official platforms or financial news sources.